ClinicalTrials.Veeva

Menu

Use of Allograft Cartilage in Cosmetic and Reconstructive Rhinoplasty

M

MTF Biologics

Status

Completed

Conditions

Rhinoplasty

Treatments

Other: Autologous Costal Cartilage Graft
Other: Costal Cartilage Allograft.

Study type

Interventional

Funder types

Other

Identifiers

NCT05566808
MTF Profile Study

Details and patient eligibility

About

This is a single-center, blinded, controlled trial, conducted in healthy adult subjects undergoing a reconstructive or cosmetic rhinoplasty involving the use of cartilaginous graft (either non-irradiated cartilage sheet allograft compared to autologous harvest and grafting of costal cartilage).

Enrollment

50 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subject is scheduled to undergo a reconstructive or cosmetic surgical procedure to alter the appearance of the nose that is anticipated to require a cartilage graft.
  • Subject is willing to sign an informed consent.
  • Subject is a non-smoker or has stopped smoking at least 6-weeks prior to inclusion in the study.
  • Subjects must agree to forgo any treatment, medical or non-medical, to the area treated in this study, for the duration of the 1-year post-treatment evaluation period, unless there is prior approval from the investigator.

Exclusion criteria

  • Presence of significant endocrine, immunologic, dermatologic or psychiatric abnormalities that would render the subject an inappropriate candidate for the study.
  • Presence of any malignancy not considered cured in the midface area specifically (no evidence of cancer recurrence in the previous five years).
  • History of radiation to the area(s) to be treated in the study.
  • Subjects taking chronic steroids (injected or oral) or other immune modulators.
  • Subjects with a history of skin sensitivity (dermatitis) to either the suture materials or dressings to be utilized during the course of this study.
  • Subjects with skin conditions that could result in poor healing or widened scars.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

Autologous Costal Cartilage Graft
Other group
Description:
Patients undergoing rhinoplasty will receive autologous rib graft.
Treatment:
Other: Autologous Costal Cartilage Graft
Costal Cartilage Allograft
Other group
Description:
Patients undergoing rhinoplasty will receive costal cartilage allograft.
Treatment:
Other: Costal Cartilage Allograft.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems